Related Experiment Video

Updated: Jul 13, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

[Interrelation between lipid peroxidation and indices of hemocoagulation in patients with chronic heart failure

N G Maliukova

    Likars'Ka Sprava
    |August 9, 2007
    PubMed

    Insights

    This study reveals that lipid peroxidation and hemocoagulation correlations in chronic heart failure (CHF) depend on decompensation severity. Early CHF stages show direct links between lipid by-products and clotting time.

    Area of Science:

    • Cardiology
    • Biochemistry
    • Hematology

    Context:

    • Investigates chronic heart failure (CHF) in 26 subjects with ischemic heart disease.
    • Focuses on the interplay between lipid peroxidation, antioxidant systems, and hemocoagulation.
    • Examines how these interactions change with the severity of heart failure decompensation.

    Purpose:

    • To determine the correlation between lipid peroxidation, antioxidant system indices, and hemocoagulation in chronic heart failure patients.
    • To elucidate how these correlations vary across different stages of CHF decompensation.

    Summary:

    • A close direct interrelation was observed between lipid peroxidation by-products and prothrombin time (PT) in stage I CHF.
    • Stage IIA CHF showed a negative interrelation between common lipids and recalcification time, and vitamin A with fibrinogen F.
    • Stage II CHF exhibited direct interrelations between lipids, vitamins E and A, and prothrombin index, with inverse correlation to PT; catalase activity inversely correlated with fibrinogen F.

    Impact:

    • Highlights the dynamic relationship between metabolic processes and coagulation in heart failure progression.
    • Provides insights into potential biomarkers for assessing CHF severity and decompensation.
    • Suggests a basis for targeted therapeutic strategies modulating lipid metabolism and coagulation pathways in CHF.

    More Related Videos

    Ferric Chloride-induced Murine Thrombosis Models10:37

    Ferric Chloride-induced Murine Thrombosis Models

    Published on: September 5, 2016

    Related Concept Videos

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

    Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

    Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
    These markers indicate stress or strain on the heart muscle:
    Natriuretic Peptides (BNP)
    Cardiac myocytes produce these hormones in response to ventricular stretching...
    Heart Failure I: Introduction01:27

    Heart Failure I: Introduction

    Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...